TY  - GEN
AU  - Roll,Petra
AU  - Ostermeier,Eva
AU  - Haubitz,Marion
AU  - Lovric,Svjetlana
AU  - Unger,Leonore
AU  - Holle,Julia
AU  - Kötter,Ina
AU  - Henes,Jörg C
AU  - Bergner,Raoul
AU  - Rubbert-Roth,Andrea
AU  - Specker,Christof
AU  - Schulze-Koops,Hendrik
AU  - Müller-Ladner,Ulf
AU  - Fleck,Martin
AU  - Burmester,Gerd-Rüdiger
AU  - Hiepe,Falk
AU  - Heitmann,Stefan
AU  - Aringer,Martin
AU  - Fischer-Betz,Rebecca
AU  - Dörner,Thomas
AU  - Tony,Hans-Peter
TI  - Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)
SN  - 1499-2752
PY  - 2013///0702
KW  - Adult
KW  - Aged
KW  - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
KW  - drug therapy
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - adverse effects
KW  - Antirheumatic Agents
KW  - Cohort Studies
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Germany
KW  - epidemiology
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Registries
KW  - Retrospective Studies
KW  - Rituximab
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3899/jrheum.120482
ER  -